Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$1.04 - $1.34 $82,652 - $106,495
-79,474 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$1.18 - $1.64 $93,779 - $130,337
79,474 New
79,474 $110,000
Q2 2021

Aug 16, 2021

SELL
$1.51 - $2.29 $67,346 - $102,134
-44,600 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$1.17 - $2.33 $52,182 - $103,918
44,600 New
44,600 $93,000
Q4 2020

Feb 12, 2021

SELL
$1.0 - $1.47 $3,153 - $4,634
-3,153 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$1.09 - $2.21 $3,428 - $6,950
-3,145 Reduced 49.94%
3,153 $3,000
Q2 2020

Aug 17, 2020

BUY
$1.8 - $3.05 $11,336 - $19,208
6,298 New
6,298 $16,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $365M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.